1Stock1.com
Google
 
1Stock1 Home
Financial Ratios
Mutual Fund Investing Terms
Option Trading Terms 
Stock Investing Terms
Alexion Pharmaceuticals, Inc. (ALXN) Yearly Returns
     Year
  Beginning Price
  Ending Price
  Gain or Loss
  Percent Gain or Loss
1997
8.6875
12.50
3.8125
43.88%
1998
12.50
13.375
0.875
7.00%
1999
13.375
30.125
16.75
125.23%
2000
30.125
64.9375
34.8125
115.56%
2001
64.9375
24.44
-40.4975
-62.36%
2002
24.44
14.12
-10.32
-42.23%
2003
14.12
17.01
2.89
20.47%
2004
17.01
25.20
8.19
48.15%
2005
25.20
20.25
-4.95
-19.64%
2006
20.25
40.39
20.14
99.46%
2007
40.39
75.03
34.64
85.76%
2008
75.03
72.38*
-2.65
-3.53%
2009
36.19
48.82
12.63
34.90%
2010
48.82
80.55
31.73
64.99%
2011
80.55
71.50
-9.05
-11.24%
2012
71.50
93.74
22.24
31.10%
2013
93.74
132.884
39.144
41.76%
2014
132.884
185.03
52.146
39.24%
2015
185.03
190.75
5.72
3.09%
2016
190.75
122.35
-68.40
-35.86%
2017
122.35
119.59
-2.76
-2.26%
2018
119.59
97.36
-22.23
-18.59%
2019
97.36
108.15
10.79
11.08%
2020
108.15
156.24
48.09
44.47%
2021
156.24
183.740475*
27.500475
17.60%
*The 2008 ending price for Alexion Pharmaceuticals has been adjusted for a 2 for 1 stock split.
*In 2021, Alexion Pharmaceuticals (ALXN) was acquired by AstraZeneca (AZN). ALXN shareholders received $60 in cash and 2.1243 shares of AZN for every share of ALXN held.
Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).
Disclaimer/Contact Us
Stock Performance Guide         
Yearly Stock Returns Index     
Back to Yearly Stock Returns Index
Articles
From
1stock1.com